EVOLUS, INC. Contractual Obligation
EVOLUS, INC. (EOLS) had Contractual Obligation of $33.08 million as of 2025-03-31, per its 10-Q filed 2025-05-07.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:ContractualObligation · last filed 2025-05-07
- 2025-03-31: Contractual Obligation $33.08M.
- 2024-12-31: Contractual Obligation $33.55M.
- 2024-09-30: Contractual Obligation $34.60M.
- 2024-06-30: Contractual Obligation $34.60M.
| Period end | Contractual Obligation | Contractual Obligation as first filed |
|---|---|---|
| 2025-03-31 | $33.08M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $33.55M 10-Q · filed 2025-05-07 | |
| 2024-09-30 | $34.60M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $34.60M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $35.40M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $36.20M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $38.70M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $39.10M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $39.60M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $39.85M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $39.00M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $39.20M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $39.30M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $39.43M 10-K · filed 2023-03-08 | |
| 2021-09-30 | $39.00M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $38.70M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $38.30M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $38.10M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $31.50M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $35.10M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $32.90M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $41.20M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $44.57M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $43.77M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $45.90M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $50.20M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $51.10M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $48.80M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $40.60M 10-Q · filed 2018-05-10 | |
| 2018-02-12 | $39.70M 10-K · filed 2020-02-25 | $40.60M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |